Product Information
TEMOZOLOMIDE 140 MG CAPSULE is a generic product labeled by Nivagen Pharmaceuticals Inc., priced at $8.3047 per EA under NDC 75834014414. Its NADAC has been published 68 times since Feb 23, 2022.
Strength
140 mg/1
Manufacturer
Nivagen Pharmaceuticals Inc.NDC
75834014414
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
2/19/2025
Active Ingredients
TEMOZOLOMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA213328On Market Since
12/7/2021
Pharmacological Classes
Price Statistics
The NADAC for TEMOZOLOMIDE 140 MG CAPSULE has been published 68 times since Feb 23, 2022, and over the history we have for it it has declined 40.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.3047 per EA |
|---|---|
| All-time high | $13.8362 (Jul 13, 2022) |
| All-time low | $6.5705 (Aug 21, 2024) |
| Median price | $10.7251 |
| Average price | $10.3530 |
| Largest weekly change | -38.7% (Aug 21, 2024) |
| Weeks tracked | 68 |
| Tracking since | Feb 23, 2022 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TEMOZOLOMIDE 140 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TEMOZOLOMIDE 140 MG CAPSULE, manufactured by Nivagen Pharmaceuticals Inc., is $8.3047 per EA (NDC 75834014414), effective Mar 5, 2025.
How has the price of TEMOZOLOMIDE 140 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TEMOZOLOMIDE 140 MG CAPSULE has declined 40.0%. It has been tracked across 68 weekly CMS publications since Feb 23, 2022.
What are the highest and lowest recorded NADAC prices for TEMOZOLOMIDE 140 MG CAPSULE?
Since Feb 23, 2022, the NADAC for TEMOZOLOMIDE 140 MG CAPSULE has ranged from a low of $6.5705 (Aug 21, 2024) to a high of $13.8362 (Jul 13, 2022), with a median of $10.7251 per EA.
Are there cheaper alternatives to TEMOZOLOMIDE 140 MG CAPSULE?
2 NADAC-published products share the same active ingredient, strength, and dosage form as TEMOZOLOMIDE 140 MG CAPSULE, but none are currently priced below it.
Who manufactures TEMOZOLOMIDE 140 MG CAPSULE?
TEMOZOLOMIDE 140 MG CAPSULE (NDC 75834014414) is labeled by Nivagen Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification